Loading...

CytomX Therapeutics, Inc.

CTMX•NASDAQ
Healthcare
Biotechnology
$2.35
$0.16(7.31%)

CytomX Therapeutics, Inc. (CTMX) Stock Chart & Performance Analysis

Explore CytomX Therapeutics, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-1.14%
5-Day Change
-10.07%
1-Month Change
-26.15%
3-Month Change
-43.80%
6-Month Change
-55.84%
Year-to-Date (YTD) Change
-53.34%
1-Year Change
-76.45%
3-Year Change
-80.83%
5-Year Change
-94.44%
All-Time (Max) Change
-96.17%

Analyzing CytomX Therapeutics, Inc. (CTMX) Trends Across Multiple Time Frames

CytomX Therapeutics, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. CytomX Therapeutics, Inc. stock shows -1.14% 1-day change, indicating low volatility, while its 5-day change of -10.07% suggests a broader trend. Over a 1-month period, a -26.15% drop could signal a pullback, whereas a 3-month decline of -43.80% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -55.84% and a YTD drop of -53.34% might concern investors, but a 1-year loss of -76.45% and a 3-year drop of -80.83% could indicate resilience. The 5-year surge of -94.44% highlights weak historical growth, while the all-time return of -96.17% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;